Human papillomavirus type 16 sequence variants: Identification by E6 and L1 lineage-specific hybridization

Journal of Clinical Microbiology

Volumn 35, Issue 1, 1997, Pages 11-19

  Wheeler, Cosette M ^a   Yamada, Takashi ^a,c   Hildesheim, Allan ^b   Jenison, Steven A ^a,d  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Department of Cell Biology ^*  (Japan)

^d NEW MEXICO DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE AMPLIFICATION; GENE SEQUENCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS TYPING; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0031060050     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.1.11-19.1997     Document Type: Article

References (70)

1. Bauer, H. M., C. E. Greer, and M. M. Manos. 1992. Determination of genital HPV infection using consensus PCR.. p. 131-152. In H. C. S. and J. O. D. McGee (ed.), Diagnostic molecular pathology: a practical approach. Oxford Universitv Press. Oxford, United Kingdom.
2. Bauer, H. M., A. Hildesheim, M. H. Schiffman, A. G. Glass, B. B. Rush, D. R. Scott, D. M. Cadell, R. J. Kurman, and M. M. Manos. 1993. Determinants of genital human papillomavirus infection in low-risk women in Portland. Oregon. Sex. Transm. Dis. 20:274-278.
3. Becker, T. M., C. M. Wheeler, N. S. McGough, C. A. Parmenter, S. W. Jordan, C. A. Stidley, R. S. McPherson, and M. H. Dorin. 1994. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 271:1181-1188.
4. Bernard, H.-U. Personal communication.
5. Bosch, F. X., M. M. Manos, N. Muñoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, and I. B. S. C. C. Study Group. 1945. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
6. Bubb, B., D. J. McCance, and R. Schlegel. 1988. DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein. Virology 163:243-246.
7. Chan, S.-Y., L. Ho, C.-K. Ong, V. Chow, B. Drescher, M. Dürst, J. ter Meulen, L. Villa, J. Luande, H. N. Mgaya, and H.-U. Bernard. 1992. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 66:2057-2066.
8. Conrad-Stöppler, M., K. Ching, H. Stöppier, K. Clancy, F. X. Bosch, N. Muñoz, K. Shah, R. Schlegel, and J. Icenogle. 1996. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol. 70: 6987-6993.
9. Deau, M.-C., M. Favre, S. Jablonska, L.-A. Rueda, and G. Orth. 1993. Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5). and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis. J. Clin. Microbiol. 31:2918-2926.
10. Deau, M.-C., M. Favre, and G. Orth. 1991. Genetic heterogeneity among papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 184:492-503.
11. de Villiers, E.-M. 1994. Human pathogenic papillomavirus types: an update. Curr. Top. Microbiol. Immunol. 186:1-12.
12. Ellis, J. R. M., P. J. Keating, J. Baird, E. F. Hounsell, D. V. Renouf, M. Rowe, D. Hopkins, M. F. Duggan-Keen, J. S. Bartholomew, L. S. Young, and P. L. Stern. 1995. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature (Medicine) 1:464-470.
13. Eluf-Neto, J., M. Booth, N. Muñoz, F. X. Bosch. C. J. L. M. Meijer, and Walboomers. 1994. Human papillomavirus and invasive cervical cancer in Brazil. Br. J. Cancer 69:114-119.
14. Eschle, D., M. Dürst, J. ter Meulen, J. Luande, H. C. Eberhardt, M. Pawlita, and L. Gissmann. 1992. Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J. Gen. Virol. 73:1829-1832.
15. Franco, E. L., L. L. Villa, P. Rahal, and A. Ruiz. 1994. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J. Natl. Cancer Inst. 86:1558-1559.
16. Fujinaga, Y., K. Okazawa, Y. Ohashi, Y. Yamakawa, M. Fukushima, I. Kato, and K. Fujinaga. 1990. Human papillomavirus type 16 E7 gene sequence in human cervical carcinoma analysed by polymerase chain reaction and direct sequencing. Tumor Res. 25:85-91.
17. Fujinaga, Y., K. Okazawa, A. Nishikawa, Y. Yamakawa, M. Fukushima, I. Kato, and K. Fujinaga. 1994. Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 9:85-92.
18. Gravitt, P., and M. Manos. 1992. PCR-based methods for the detection of human papillomavirus DNA, p. 121-133. In N. Muñoz, F. X. Bosch, K. Shah, and A. Meheus (ed.), The epidemiology of cervical cancer and human papillomavirus. Publication 119. IARC Scientific, Lyon, France.
19. Halbert, C. L., and D. A. Galloway. 1988. Identification of the E5 open reading frame of human papillomavirus type 16. J. Virol. 62:1071-1075.
20. Hecht, L., A. S. Kadish, G. Jiang, and R. D. Burk. 1995. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer 60:369-376.
21. Heinzel, P. A., C.-Y. Chan, L. Ho, M. O'Connor, P. Balaram, M. S. Campo, K. Fujinaga, N. Kiviat, J. Kuypers, H. Pfister, B. M. Steinberg, S.-K. Taj, L. L. Villa, and H.-U. Bernard. 1995. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J. Clin. Microbiol. 33:1746-1754.
22. Hildesheim, A., P. Gravitt, M. H. Schiffman, R. J. Kurman, W. Barnes, S. Jones. J.-G. Tchabo, L. A. Brinton, C. Copeland, J. Epp, and M. M. Manos. 1993. Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex. Transm. Dis. 20:279-284.
23. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, R. J. Kurman, and M. M. Manos. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
24. Ho, G. Y. G., R. D. Burk, S. Klein, A. S. Kadish, C. J. Chang, P. Palan, J. Basu, R. Tachezy, R. Lewis, and S. Romney. 1995. Persistent genital human papillomavirus as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 87:1365-1371.
25. Ho, L., S.-K. Chan, and H.-U. Bernard. 1993. Sequence variation of human papillomavirus type 16 from couples suggest transmission with low infectivity and polyclonality in cenital neoplasia. J. Infect. Dis. 168:83-89.
26. Ho, L., S.-Y. Chan, R. D. Burk, B. C. Das, K. Fujinasa, J. P. Icenogle, T. Kahn, N. Kiviat, W. Lancaster, P. Mavromara-Nazos, V. Labropoulou, S. Mitrani-Rosenbaum, M. Norrild, M. R. Pillai, J. Stoerker, K. Syrjänen, S. Syrjänen S.-K. Tay, L. L. Villa, C. M. Wheeler, A.-L. Williamson, and H.-U. Bernard. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstruction prehistoric viral spread and the movement of ancient human populations. J. Virol. 67:6413-6423.
27. Ho, L., S.-Y. Chan, V. Chow, T. Chong, S.-K. Tay, L. L. Villa, and H.-U. Bernard. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J. Clin. Microbiol. 29:1765-1772.
28. Icenogle, J. P., K. A. Clancy, and S. Y. Lin. 1995. Sequence variation in the capsid protein genes of human papillomavirus type 16 and type 31. Virology 214:664-669.
29. Icenogle, J. P., M. Laga, D. Miller, R. A. Tucker, and W. C. Reeves. 1992. Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J. Infect. Dis. 166:1210-1216.
30. Icenogle, J. P., P. Sathya, D. L. Miller, R. A. Tucker, and W. E. Rawls. 1991. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 184: 101-107.
31. Jacobs, M. V., A. M. de Roda Husman, A. J. C. van den Brule, P. J. F. Snijders, D. J. L. M. Meijer, and J. M. M. Walboomers. 1995. Group-specific differentiation between high-and low-risk human papillomavirus genotypes of general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol. 33:901-905.
32. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Durst, L. Gissmann, D. R. Lowy, and J. T. Schille. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
33. Koutsky, L., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intrepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327: 1272-1278.
34. Li, W. H., C. C. Luo, and C. I. Wu. 1985. Evolution of DNA sequence, p. 1-94. In Molecular evolutionary genetics. Plenum Press, New York, N.Y.
35. Londesborough, P., L. Ho, G. Terry, J. Cuzick, C. Wheeler, and A. Singer. Human papillomavirus (HPV) genotype as a predictor of persistence and development of high grade lesions in women with minor cervical abnormalities. Int. J. Cancer, in press.
36. Lungu, O., X. W.Sun, T. C. J. Wright, A. Ferenczy, R. M. Richart, and S. Silverstein. 1995. A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet. Gynecol. 85:337-342.
37. Manos, M. M., Y. Ting, D. K. Wright, A. J. Lewis, T. R. Broker, and S. M. Wolinsky. 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
38. Matsukura, T., T. Kanda, A. Furuno, H. Yoshikawa, T. Kawana, and K. Yoshiike. 1986. Cloning of monomer human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J. Virol. 58:979-982.
39. Morrison, E. A., G. Ho, and S. H. Vermund. 1991. HPV infection and other risk factors for cervical neoplasia: a case-control study. Int. J. Cancer 49:6-13.
40. Muñoz, N. 1992. HPV and cervical cancer, p. 251-262. In N. Muñoz, F. Bosch, and K. Shah (ed.), The epidemiology of cervical cancer and human papillomavirus. Publication 110. IARC Scientific, Lyon, France.
41. Muñoz, N., F. X. Bosch, S. de Sanjosé, L. Tafur, I. Izarzugaza, M. Gili, P. Viladiu, C. Navarro, C. Martos, N. Ascunce, L. C. Gonzalez, J. M. Kaldor, E. Guerrero, A. Lörinez, M. Santamaria, P. Alonso de Ruiz, N. Aristizabal, and K. Shah. 1992. The causal link between human papillomavirus and cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 52:743-749.
42. Muñoz, N., L. Crawford, and P. Coursaget. 1995. HPV vaccines and their potential use in the prevention and treatment of cervical neoplasia. Papillomavirus Rep. 6:54-55.
43. Myers, G., H.-U. Bernard, H. Delius, C. Baker, J. Icenogle, A. Halpern, and C. Wheeler. 1995. A compilation of analysis of nucleic acid and amino acid sequences. Publication LA-UR 95-3675. Los Alamos National Laboratory, Los Alamos, N.M.
44. Myers, G., H.-U. Bernard, H. Delius, M. Favre, J. Icenogle, M. van Ranst, and C. Wheeler. 1994. Human papillomaviruses. A compilation and analysis of nucleic acid and amino acid sequences. Publication LA-UR 94-0000. Los Alamos National Laboratory, Los Alamos, N.M.
45. Ong, C.-K., S.-Y. Chan, M. S. Campo, K. Fujinanga, P. Mavromara, H. Pfizer, S.-K. Tay, J. Ter Meulen, L. L. Villa, and H.-U. Bernard, im Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 67:6424-6431.
46. Papillomavirus Nomenclature Committee. 1994. In Proceedings of the 13th International Papillomavirus Conference.
47. Parton, A. 1990. Nucleotide sequence of the HPV16 L open reading frame. Nucleic Acids Res. 18:3631.
48. Pushko, P., T. sasagawa, J. Cuzick, and L. Crawford. 1994. Sequence variation in the capsid protein genes of human papillomavirus type 16. J. Gen. Virol. 75:911-916.
49. Ramesar, J. E., E. P. Rybicki, and A.-L. Williamson. 1995. Sequence variation in the L1 gene of human papillomavirus type 16 from Africa. Arch. Virol. 140:1863-1870.
50. Resnick, R. M., M. T. E. Cornelissen, D. K. Wright, G. H. Eichinger, H. S. Fox, J. ter Schegget, and M. M. Manos, 1990. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst. 82:1477-1484.
51. Sanger, F., S. Nicklen, and A. Coulson. 1977. DNA sequencing with chainterminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
52. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholer, C. K. Stanton, and M. M. Manos. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
53. Seedorf, K., G. Krämmer, M. Dürst, S. Suhai, and W. G. Röwenkamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
54. Smits, H. L., K. F. Traanberg, M. R. L. Krul, P. R. Prussia, C. L. Kuiken, M. F. Jebbink, J. A. F. W. Kleyne, R. H. van den Berg, B. Capone, A. de Bruyn, and J. ter Scheret. 1994. Identification of a unique group of human papillomavirus type 16 sequence variants among clinical isolates from Barbados. J. Gen. Virol. 75:2457-2462.
55. Stewart, A.-C. M., A. M. Eriksson, M. M. Manos, N. Muñoz, F. X. Bosch, J. Peto, and C. M. Wheeler. 1996. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J. Virol. 70:3127-3136.
56. ter Meulen, J., A. C. Schweigler, H. C. Eberhardt, J. Luade, H. N. Mgaya, M. Muller, C. Bleul, V. Ulken, H. Ikenberg, and A. M. Pawlita. 1993. Sequence variation in the E7 gene of human papillomavirus type 18 in tumor and non-tumor patients and antibody response to a conserved epitope. Int. J. Cancer. 53:257-259.
57. Tieben, L. M., J. ter Schegget, R. P. Minnaar, J. N. Bouwees Bavinck, R. M. Berkhout, B. J. Vermeer, M. F. Jebbink, and H. L. Smits. 1993. Detection of cuntaneous and genital HPV types in clinical samples by PCR using consensus primers. J. Virol. Methods 42:265-280.
58. van Belkum, A. 1995. Low-stringency single specific primer PCR, DNA sequencing and single-strand conformation polymorphism of PCR products for identification of genetic variants of human papillomavirus type 16. J. Virol. Methods 55:435-443.
59. van Belkum, A., L. Juffermans, L. SchrauWen, G. van Doornum, M. Burger, and W. Quint. 1995. Genotyping human papillomavirus type 16, isolates from persistently infected promiscuous individuals and cervical neoplasia patients. J. Clin. Microbiol. 33:2957-2962.
60. van den Brule, A. J. C., E. C. J. Class, M. du Maine, W. J. G. Melchers, T. Helmerhorst, W. G. V. Quint, J. Lindeman, C. J. L. M. Meijer, and J. M. M. Walboomers. 1989. Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies. J. Med. Virol. 29:20-27.
61. van den Brule, A. J. C., C. J. L. M. Meijer, V. Gakels, P. Kenemans, and J. M. M. Walboomers. 1990. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J. Clin. Microbiol. 28:2739-2743.
62. van den Brule, A. J. C., P. J. F. Snijders, C. J. L. M. Meijer, and J. M. M. Walboomers. 1993. PCR-based detection of genital HPV genotypes: an up-date and future perspectives. Papillomavirus Rep. 4:95-99.
63. Van Ranst, M. A., R. Tachezy, H. Delius, and R. D. Burk. 1993. Taxonomy of the human papillomaviruses. Papillomavirus Rep. 4:61-65.
64. Wheeler, C. M., J. R. Herron, R. J. Apple, H. A. Erlich, J. Deacon, F. Matthews, and J. Peto. Unpublished data.
65. Wheeler, C. M., A. Hildesheim, and M. Schiffman. Human papillomavirus (HPV) type 16 E6 nucleotide variations as cervical disease correlates. Submitted for publication.
66. Wheeler, C. M., C. A. Parmenter, W. C. Hunt, T. M. Becker, C. E. Greer, A. Hildesheim, and M. M. Manos. 1993. Determinants of genital human papillomavirus infection among cytologically normal women attending the Unversity of New Mexico Student Health Center. Sex. Transm. Dis. 20:286-289.
67. Xi, L. F., G. W. Demers, L. A. Koutsk, N.B. Kiviat, J. Kuypers, H. Watts, K.K. Holmes, and D. A. Galloway. 1995. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J. Intect. Dis. 172:747-755.
68. Xi, L. F., L. A. Koutsky, J. Kuypers, D. A. Galloway, J. P. Hughes, C. M. Wheeler, K. K. Holmes, and N. B. Kiviat. Risk of cervical intraepithelial neoplasia grade 2-3 in relation to human papillomavirus type 16 variants. Submitted for publication.
69. Yamada, T., M. M. Manos, J. Peto, C. E. Greer, N. Muñoz, F. X. Bosch, and C. M. Wheeler. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. Submitted for publication.
70. Yamada, T., C. M. Wheeler, A. L. Halpern, A.-C. M. Stewart, A. Hildesheim, and S. A. Jenison. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69:7743-7753.